Medicine & Life Sciences
Transplant Recipients
100%
HIV
91%
Cytomegalovirus
90%
Infections
83%
Coronavirus
61%
Transplants
58%
Adenoviridae
53%
Cytomegalovirus Infections
51%
Liver Transplantation
48%
T-Lymphocytes
45%
HIV-1
44%
Therapeutics
41%
Antiviral Agents
39%
Virus Diseases
38%
HIV Infections
38%
Viruses
36%
Vaccines
36%
Organ Transplantation
31%
Endocarditis
31%
Equipment and Supplies
30%
Apoptosis
28%
Hepacivirus
28%
SARS Virus
27%
Human Herpesvirus 6
26%
Opportunistic Infections
25%
Mortality
24%
Serogroup
24%
Transplantation
24%
Community-Based Participatory Research
22%
Pharmaceutical Preparations
21%
Vaccination
21%
Severe Acute Respiratory Syndrome
19%
Tuberculosis
19%
Bacteremia
19%
Retroviridae Infections
19%
Immunization
18%
Refugees
18%
Kidney
18%
Pandemics
17%
Ganciclovir
17%
Protease Inhibitors
17%
Genes
17%
Allografts
16%
Joints
16%
Human Influenza
16%
Proteins
16%
Propionic Acidemia
15%
Cell Death
15%
Genetic Therapy
15%
Chronic Hepatitis C
15%
Tissue Donors
15%
Epidemiology
15%
DNA
14%
Viremia
14%
Immunocompromised Host
13%
Population
13%
Liver
13%
Lung
13%
Confidence Intervals
12%
HIV Protease Inhibitors
12%
Hematopoietic Stem Cells
12%
Incidence
12%
Valganciclovir
12%
Monoclonal Antibodies
12%
Adenovirus Vaccines
12%
Viral Load
11%
Cohort Studies
11%
Human Adenoviruses
11%
Cryptococcosis
11%
Mycoses
11%
Anti-Bacterial Agents
11%
Caspase 8
11%
In Vitro Techniques
11%
Ritonavir
11%
Hospitalization
11%
Safety
11%
Polymerase Chain Reaction
11%
Fever
10%
Herpesviridae Infections
10%
Acquired Immunodeficiency Syndrome
10%
Reverse Transcriptase Inhibitors
10%
Hematopoietic Stem Cell Transplantation
10%
Toll-Like Receptor 2
10%
AIC246
10%
Communicable Diseases
10%
lens epithelium-derived growth factor
10%
Ribavirin
10%
Nelfinavir
9%
Human Herpesvirus 7
9%
Peptides
9%
Highly Active Antiretroviral Therapy
9%
Morbidity
9%
Anti-Retroviral Agents
9%
Feline Immunodeficiency Virus
9%
Staphylococcus aureus
9%
Antigens
9%
Kidney Transplantation
9%
Ligands
9%
Invasive Fungal Infections
9%
Heme Oxygenase-1
9%